Background: In the developing world the leading cause of seizures and epilepsy is neurocysticercosis caused by the larvae of Taenia solium . Neurocysticercosis is diagnosed by Computed Tomography (CT), Magnetic Resonance Imaging (MRI) or by serological tests on serum or cerebro spinal fluid. We evaluated the role of conventional MRI and serum anti bodies to cysticercal vasicular fluid antigen in patients with seizures diagnosed as neurocysticercosis by CT. Methods: Plain and gadolinium-enhanced MRI of brain in 51 patients, and ELISA to detect IgG antibodies in the serum to cysticercal vesicular fluid antigen in 44 patients, were performed. Results: The lesions observed were predominantly Single enhancing CT lesions (SECTL) in 36(70.5%) of the 51 patients studied; they were confined to the brain parenchyma in 50(98%) of the patients. There was no statistically significant difference in the number of lesions detected by CT or MRI in the brain parenchyma. IgG antibodies to cysticercal antigen could be detected in 11(24.8%) of the 44 patients tested by ELISA.
Conclusion:In the patient population studied, MRI did not contribute much in the diagnosis of neurocysticercosis over CT in terms of number of lesions detected. Serology was found to be useful in the diagnosis of neurocysticercosis in only about a quarter of patients diagnosed by imaging modalities.
Neonatal small left colon syndrome (NSLCS) is one of the suspected diagnoses if the neonate does not pass meconium within 24 h of birth. Radiological contrast studies play a vital role in diagnosing and treating the entity. We report a case where the newborn did not pass meconium till 4 days of birth and which on gastrografin studies was diagnosed as a case of NSLCS.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.